191 related articles for article (PubMed ID: 29736168)
21. Long-term outcome of salvage high-dose chemotherapy in patients with germ cell tumor with poor prognostic features.
De Giorgi U; Rosti G; Salvioni R; Papiani G; Ballardini M; Pizzocaro G; Marangolo M
Urol Oncol; 2011; 29(3):284-90. PubMed ID: 19556152
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic efficacy of high-dose chemotherapy with autologous stem-cell transplantation in 44 relapsed or refractory germ-cell tumor patients: A retrospective cohort study.
Ferhatoglu F; Paksoy N; Khanmammadov N; Yildiz A; Ahmed MA; Gülbas Z; Basaran M
Medicine (Baltimore); 2024 Feb; 103(8):e37213. PubMed ID: 38394499
[TBL] [Abstract][Full Text] [Related]
23. High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumors.
Lorch A; Neubauer A; Hackenthal M; Dieing A; Hartmann JT; Rick O; Bokemeyer C; Beyer J
Ann Oncol; 2010 Apr; 21(4):820-825. PubMed ID: 19822531
[TBL] [Abstract][Full Text] [Related]
24. Outcomes of Autologous Stem Cell Transplantation (ASCT) in Relapsed/Refractory Germ Cell Tumors: Single Center Experience from Turkey.
Yildiz F; Durnali A; Eraslan E; Ilhan A; Tufan G; Aslan F; Arslan UY; Alkis N; Demirci U; Altuntas F; Oksuzoglu B
Urol J; 2020 Aug; 17(5):497-500. PubMed ID: 32869258
[TBL] [Abstract][Full Text] [Related]
25. Current chemotherapeutic approaches for recurrent or refractory germ cell tumors.
O'Carrigan B; Grimison P
Urol Oncol; 2015 Aug; 33(8):343-54. PubMed ID: 25308563
[TBL] [Abstract][Full Text] [Related]
26. The role of high-dose chemotherapy in relapsed germ cell tumors.
Rick O; Kollmannsberger C; Hartmann JT; Braun T; Siegert W; Bokemeyer C; Beyer J
World J Urol; 2004 Apr; 22(1):25-32. PubMed ID: 15034739
[TBL] [Abstract][Full Text] [Related]
27. Maintenance Oral Etoposide After High-Dose Chemotherapy (HDCT) for Patients With Relapsed Metastatic Germ-Cell Tumors (mGCT).
Taza F; Abonour R; Zaid MA; Althouse SK; Anouti B; Akel R; Hanna NH; Adra N; Einhorn LH
Clin Genitourin Cancer; 2023 Apr; 21(2):213-220. PubMed ID: 36737276
[TBL] [Abstract][Full Text] [Related]
28. Survival outcomes of patients with germ cell tumors treated with high-dose chemotherapy for refractory or relapsing disease.
Zschäbitz S; Distler FA; Krieger B; Wuchter P; Schäfer-Eckart K; Jenzer M; Hohenfellner M; Dreger P; Haag GM; Jäger D; Pahernik S; Grüllich C
Oncotarget; 2018 Apr; 9(32):22537-22545. PubMed ID: 29854297
[TBL] [Abstract][Full Text] [Related]
29. High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes: 20-Year Follow-up of a Phase 3 Randomized Clinical Trial.
Steenbruggen TG; Steggink LC; Seynaeve CM; van der Hoeven JJM; Hooning MJ; Jager A; Konings IR; Kroep JR; Smit WM; Tjan-Heijnen VCG; van der Wall E; Bins AD; Linn SC; Schaapveld M; Jacobse JN; van Leeuwen FE; Schröder CP; van Tinteren H; de Vries EGE; Sonke GS; Gietema JA
JAMA Oncol; 2020 Apr; 6(4):528-534. PubMed ID: 31999296
[TBL] [Abstract][Full Text] [Related]
30. Salvage, dose intense and high-dose chemotherapy for the treatment of poor prognosis or recurrent germ cell tumours.
El-Helw L; Coleman RE
Cancer Treat Rev; 2005 May; 31(3):197-209. PubMed ID: 15944049
[TBL] [Abstract][Full Text] [Related]
31. The role of high-dose chemotherapy in the management of germ cell tumors.
Bastos DA; Feldman DR
Curr Opin Oncol; 2014 May; 26(3):284-93. PubMed ID: 24670607
[TBL] [Abstract][Full Text] [Related]
32. Salvage treatment for children with relapsed/refractory germ cell tumors: The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) experience.
De Pasquale MD; D'Angelo P; Crocoli A; Boldrini R; Conte M; Bisogno G; Spreafico F; Inserra A; Biasoni D; Dall'Igna P; Siracusa F; Miele E; Terenziani M
Pediatr Blood Cancer; 2020 Mar; 67(3):e28125. PubMed ID: 31850649
[TBL] [Abstract][Full Text] [Related]
33. Current trends in chemotherapy for metastatic nonseminomatous testicular germ cell tumors.
Bokemeyer C
Oncology; 1998; 55(3):177-88. PubMed ID: 9560052
[TBL] [Abstract][Full Text] [Related]
34. Current aspects of high-dose chemotherapy in germ-cell tumors.
Rick O; Kollmannsberger C; Beyer J; Bokemeyer C
Crit Rev Oncol Hematol; 2003 Sep; 47(3):237-48. PubMed ID: 12962898
[TBL] [Abstract][Full Text] [Related]
35. Consensus Recommendations from the Spanish Germ Cell Cancer Group on the Use of High-dose Chemotherapy in Germ Cell Cancer.
González-Billalabeitia E; Sepúlveda JM; Maroto P; Aparicio J; Arranz JA; Esteban E; Gironés R; López-Brea M; Mendez-Vidal MJ; Pinto A; Sastre J; de Prado DS; Terrasa J; Vázquez S; Powles T; Beyer J; Castellano D; Del Muro XG;
Eur Urol Focus; 2017 Apr; 3(2-3):280-286. PubMed ID: 28753776
[TBL] [Abstract][Full Text] [Related]
36. Survival Outcomes After High-dose Chemotherapy and Stem Cell Transplantation in the Salvage Setting for Relapsed or Refractory Germ Cell Cancers.
Sharma A; Babra DS; Joshi PV; Hall M; Gogbashian A; Vasdev N; Joseph M; Yazdan A; Kanfer E
In Vivo; 2020; 34(6):3675-3679. PubMed ID: 33144484
[TBL] [Abstract][Full Text] [Related]
37. Treatment of patients with relapsed and/or cisplatin-refractory metastatic germ cell tumours: an update.
Koychev D; Oechsle K; Bokemeyer C; Honecker F
Int J Androl; 2011 Aug; 34(4 Pt 2):e266-73. PubMed ID: 21790652
[TBL] [Abstract][Full Text] [Related]
38. Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors.
Motzer RJ; Nichols CJ; Margolin KA; Bacik J; Richardson PG; Vogelzang NJ; Bajorin DF; Lara PN; Einhorn L; Mazumdar M; Bosl GJ
J Clin Oncol; 2007 Jan; 25(3):247-56. PubMed ID: 17235042
[TBL] [Abstract][Full Text] [Related]
39. Survival outcomes and toxicity in patients 40 years old or older with relapsed metastatic germ cell tumors treated with high-dose chemotherapy and peripheral blood stem cell transplantation.
Agrawal V; Abonour R; Abu Zaid M; Althouse SK; Ashkar R; Albany C; Hanna NH; Einhorn LH; Adra N
Cancer; 2021 Oct; 127(20):3751-3760. PubMed ID: 34260067
[TBL] [Abstract][Full Text] [Related]
40. The status of high-dose chemotherapy with hematopoietic stem cell transplantation in germ cell tumor patients.
De Giorgi U; Rosti G; Papiani G; Marangolo M
Haematologica; 2002 Jan; 87(1):95-104. PubMed ID: 11801470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]